<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00442494</url>
  </required_header>
  <id_info>
    <org_study_id>KUH5204515</org_study_id>
    <nct_id>NCT00442494</nct_id>
  </id_info>
  <brief_title>Corticosteroids for the Prevention of Atrial Fibrillation After Cardiac Surgery</brief_title>
  <official_title>Feasibility of Corticosteroid in the Prevention of Atrial Fibrillation After Cardiac Surgery: A Prospective, Double-Blind Randomized Multicenter Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Atrial fibrillation is the most common arrhythmia to occur after cardiac surgery.
      Inflammatory response may be one etiological factor.

      We hypothesized that intravenous corticosteroid administration after cardiac surgery prevents
      AF after cardiac surgery.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study has been completed as planned
  </why_stopped>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Study couldn´t start due to investigator</measure>
    <time_frame>Study couldn´t start due to investigator</time_frame>
    <description>Study couldn´t start due to investigator</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study couldn´t start due to investigator</measure>
    <time_frame>Study couldn´t start due to investigator</time_frame>
    <description>Study couldn´t start due to investigator</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Study couldn´t start due to investigator</measure>
    <time_frame>Study couldn´t start due to investigator</time_frame>
    <description>Study couldn´t start due to investigator</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Study couldn´t start due to investigator</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Study couldn´t start due to investigator</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous hydrocortisone</intervention_name>
    <arm_group_label>Study couldn´t start due to investigator</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled to undergo their first on-pump CABG, aortic valve replacement or
             combined aortic valve replacement and CABG were enrolled.

        Exclusion Criteria:

          -  Previous episodes of AF or flutter

          -  Uncontrolled diabetes mellitus

          -  Systemic mycotic infection

          -  Active tuberculosis

          -  Cushing's syndrome

          -  Psychotic mental disorder

          -  Herpes Simplex keratitis

          -  Serum creatinine exceeding 200 µg/ml

          -  Patients were also excluded if they had a history of previous peptic ulcer or
             thrombophlebitis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jari Halonen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kuopio University Hospital</affiliation>
  </overall_official>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2007</study_first_submitted>
  <study_first_submitted_qc>March 1, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2007</study_first_posted>
  <last_update_submitted>November 15, 2012</last_update_submitted>
  <last_update_submitted_qc>November 15, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 16, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Helena Pehkonen</investigator_full_name>
    <investigator_title>assistant</investigator_title>
  </responsible_party>
  <keyword>Atrial fibrillation after cardiac surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
    <mesh_term>Hydrocortisone acetate</mesh_term>
    <mesh_term>Cortisol succinate</mesh_term>
    <mesh_term>Hydrocortisone</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 26, 2013</submitted>
    <returned>January 24, 2014</returned>
    <submitted>March 5, 2018</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

